Brandywine Global Investment Management LLC Buys New Shares in Humana Inc. (NYSE:HUM)

Brandywine Global Investment Management LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 201,432 shares of the insurance provider's stock, valued at approximately $51,105,000. Brandywine Global Investment Management LLC owned 0.17% of Humana at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd acquired a new position in shares of Humana during the third quarter valued at $404,000. Glenmede Trust Co. NA raised its position in shares of Humana by 7.6% during the 3rd quarter. Glenmede Trust Co. NA now owns 25,718 shares of the insurance provider's stock worth $8,146,000 after buying an additional 1,813 shares in the last quarter. CreativeOne Wealth LLC acquired a new stake in shares of Humana in the 3rd quarter worth approximately $208,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Humana by 1.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 856,954 shares of the insurance provider's stock valued at $271,432,000 after acquiring an additional 9,100 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its stake in shares of Humana by 13.0% during the third quarter. Public Sector Pension Investment Board now owns 5,222 shares of the insurance provider's stock valued at $1,654,000 after acquiring an additional 600 shares during the period. 92.38% of the stock is owned by institutional investors.

Remove Ads

Humana Stock Up 2.3 %

Humana stock traded up $6.04 during mid-day trading on Thursday, hitting $271.84. 621,028 shares of the company's stock were exchanged, compared to its average volume of 1,718,480. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The stock has a 50 day moving average of $268.97 and a two-hundred day moving average of $272.62. The stock has a market cap of $32.81 billion, a P/E ratio of 27.32, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is 35.58%.

Analyst Ratings Changes

A number of brokerages have issued reports on HUM. Barclays increased their price target on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Humana currently has an average rating of "Hold" and a consensus price target of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.